Influence of proton pump inhibitors and H2-receptor antagonists on the efficacy and safety of dasatinib in chronic myeloid leukemia patients
International Journal of Hematology
Vol.111 No.6：826-832 Koutake, Y., Taniguchi, J., Yasumori, N., Nagaishi, H., Eto, T., Nakashima, K., Fukazawa, M. and Hayashi, T.
2020.3
Efficacy of Primary Prophylaxis with Pegfilgrastim after Docetaxel for Castration-Resistant Prostate Cancer
Gan to kagaku ryoho. Cancer & chemotherapy Vol.46 No.11：1721ー1725
Koutake, Y., Tsurusaki, Y., Fujita, T., Inoue, D., Hanada,K. and Nakagawa, Y.
2019.11
Risk factors for delayed chemotherapy-induced nausea and vomiting with low-emetic-risk chemotherapy: a prospective, observational, multicenter study
Cancer Management and Research 10:4249-4255
Hayashi T, Shimokawa M, Matsuo K, Miyoshi T, Toriyama Y, Yokota C, Taniguchi J, Hanada K, Tsumagari K, Okubo N, Koutake Y, Sakata K, Kawamata Y, Goto T, Tsurusaki Y, Koyabu M.
2018.9
A prospective, observational, multicenter study on risk factors and prophylaxis for low emetic risk chemotherapy-induced nausea and vomiting
Supportive Care in cancer 25: 2707-2714
Hayashi T, Shimokawa M, Miyoshi T, Toriyama Y, Yokota C, Taniguchi J, Hanada K, Tsumagari K, Okubo N, Koutake Y, Sakata K, Kawamata Y, Goto T, Tsurusaki Y, Koyabu M
2017.9
